GSK China
WEB欢迎来到葛兰素史克中国. 葛兰素史克作为一家全球生物医药公司，以“汇聚科学、技术与人才，合力超越，共克疾病”为我们的愿景和使命。 使命、战略和文化. 我们是GSK. 2：47. 我们的战略. 我们推出一系列创新的疫苗、特药和普药来预防并治疗疾病。 同时运用免疫系统科学、人类遗传学和前沿技术的研发方式。 我们的研发专注于四大治疗领域：传染性疾病、HIV、呼吸系统疾病/免疫学、肿瘤学。 使命、战略和文化. 传染性疾病. 1/3. 一生中会得 …
GSK China scandal - Wikipedia
WEBThe GSK China scandal unfolded when the China division of the global drugmaker GlaxoSmithKline (GSK) admitted to engaging in bribery to promote its products within the Chinese market.
GSK and Zhifei announce exclusive strategic vaccine partnership in China
WEBOct 9, 2023 · GSK plc (LSE/NYSE: GSK) announced today that it has reached an exclusive agreement with Chongqing Zhifei Biological Products, Ltd. (Zhifei) to co-promote GSK’s shingles vaccine, Shingrix, in China for an initial three-year period, with the potential to extend the partnership should all parties agree. Zhifei, the largest Chinese vaccine ...
GSK on hunt for drug deals in China - Financial Times
WEBDec 17, 2023 · GSK is on the hunt for deals in China after the UK drugmaker rebuilt a “very strong” relationship with the government and local companies since a corruption scandal a decade ago.
GSK signs £2.5bn shingles vaccine deal with China’s Zhifei
WEBOct 9, 2023 · GSK has signed a deal with Zhifei, China’s largest vaccine company by revenue, as the British drugmaker aims to double global sales of its shingles vaccine by 2026.
GSK signs shingles vaccine deal with China's Zhifei for around $3 bln
WEBLONDON/SHANGHAI Oct 9 (Reuters) - China's largest vaccines company Zhifei (300122.SZ) will pay British drugmaker GSK (GSK.L) 2.5 billion pounds ($3.05 billion) for the exclusive rights to...
GSK partners up with Zhifei to market Shingrix in China - Fierce …
WEBOct 9, 2023 · A year ago, GSK said it planned to double its sales of Shingrix in China by 2025. Zhifei has a track record of success in driving sales, recording $4.75 billion in vaccine revenue in 2021,...
GSK expands presence in China through strategic cooperation to …
WEBGlaxoSmithKline (GSK) and Jiangsu Walvax Biotech Company (Walvax) today announced a cooperation agreement to form a long-term Joint Venture (JV) to develop and manufacture paediatric vaccines for use in China.
GSK signs shingles vaccine deal with China's Zhifei for around $4b
WEBOct 10, 2023 · LONDON/SHANGHAI - China’s largest vaccines company Zhifei will pay British drugmaker GSK 2.5 billion pounds (S$4.17 billion) for the exclusive rights to distribute GSK’s shingles vaccine in...
GSK China gets record fine and top executives suspended sentences
WEBSep 22, 2014 · GlaxoSmithKline’s China operation has been fined ¥3bn (£299m; €379m; $488m) after being found guilty of bribery by the Changsha Intermediate People’s Court in Hunan province.